Saturday, July 11, 2026

Drug profile · INN

bl0020

bl0020 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — bl0020
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

bl0020 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN bl0020

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. BL0020 Phase 2 · Shanghai Best-Link Bioscience · Small Cell Carcinoma of Lung
  2. Recombinant Staphylokinase Approved · First People's Hospital · ST-segment Elevation Myocardial Infarction (STEMI)

Frequently asked questions

What is bl0020?

bl0020 is an FDA-listed pharmaceutical active ingredient.